DCF — PAULDING MEDICAL CENTER
Enterprise Value: $213.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$213.5M
Enterprise Value
$55.6M
PV of Cash Flows
$158.0M
PV of Terminal Value
$254.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $297.2M | $28.2M | 9.0% | $10.4M | $9.5M |
| Year 2 | $306.1M | $32.1M | 10.0% | $13.0M | $10.8M |
| Year 3 | $315.3M | $36.2M | 11.0% | $15.8M | $11.9M |
| Year 4 | $324.8M | $38.9M | 12.0% | $17.5M | $11.9M |
| Year 5 | $334.5M | $40.9M | 12.0% | $18.6M | $11.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $213.5M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$288.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08981092187973276
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5